Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin-specific chaperone E (TBCE) is a protein involved in the second step of the tubulin folding pathway, essential for the correct folding of beta-tubulin and regulation of tubulin heterodimer dissociation[2][3][5]. TBCE works in concert with other cofactors (A, C, D, E) to ensure the proper assembly, stability, and turnover of microtubules—a process critical for cellular functions such as mitosis, intracellular transport, and maintenance of the neuronal microtubule network[1][5][6]. Mutations in TBCE are linked to rare syndromic diseases involving parathyroid dysfunction, neurodevelopmental issues, and skeletal anomalies[2][3]. TBCE is not currently a direct pharmacological target for approved drugs but may intersect with tubulin-targeting agents via its role in tubulin biogenesis[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin-specific chaperone E (TBCE).